tiprankstipranks
Neuropace, Inc. (NPCE)
NASDAQ:NPCE
US Market
NPCE
NeuroPace
RESEARCH TOOLSreports
Want to see NPCE full AI Analyst Report?

NeuroPace (NPCE) Stock News & Sentiment

135 Followers
Neuropace Warns Cybersecurity Threats to Intracranial EEG Data Could Hit Operations, Reputation and Growth
Premium
Company Announcements
Neuropace Warns Cybersecurity Threats to Intracranial EEG Data Could Hit Operations, Reputation and Growth
4d ago
NPCE
NeuroPace Earnings Call Highlights RNS Growth Momentum
Premium
Company Announcements
NeuroPace Earnings Call Highlights RNS Growth Momentum
4d ago
NPCE
NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers
Premium
Ratings
NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers
5d ago
NPCE
NeuroPace Earnings Call Highlights Growth And AI Push
Premium
Company Announcements
NeuroPace Earnings Call Highlights Growth And AI Push
2M ago
NPCE
NeuroPace: Strong 2025 Execution, Reimbursement Tailwinds, and Label Expansion Upside Support Reiterated Buy and $19 Target
Premium
Ratings
NeuroPace: Strong 2025 Execution, Reimbursement Tailwinds, and Label Expansion Upside Support Reiterated Buy and $19 Target
2M ago
NPCE
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
Premium
Company Announcements
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
2M ago
NPCE
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
NPCE
More NPCE News >

NPCE News on the Web

NeuroPace price target raised to $20 from $19 at H.C. Wainwright
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), NeuroPace (NPCE) and Avalo Therapeutics (AVTX)
TipRanks News
Bullish
Neuropace Warns Cybersecurity Threats to Intracranial EEG Data Could Hit Operations, Reputation and Growth
TipRanks News
Bearish
NeuroPace Earnings Call Highlights RNS Growth Momentum
TipRanks News
Bullish
NeuroPace (NPCE) Receives a Buy from Lake Street
TipRanks News
Bullish
NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers
TipRanks News
Bullish
NeuroPace Inc (NPCE) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus News
Bullish
Q1 2026 Neuropace Inc Earnings Call Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Very Positive
NPCE
Sector Average
Media Buzz
This Week12 articles
Weekly Average0.25 articles
News Sentiment
This Week89%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NPCE’s Media Buzz Sentiment?
12 articles about NPCE were published this week. In an average week, 0.25 articles are published.
    What is NPCE’s weekly average amount of articles?
    In an average week, 0.25 articles about NPCE are published.
      What is NPCE’s News Sentiment?
      89% of articles about NPCE were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week